Peer-influenced content. Sources you trust. No registration required. This is HCN.
Mayo Clinic
This CME program is dedicated to exploring the integration of artificial intelligence in the field of cardiology, focusing on its application for diagnosis, clinical decision support, and improving the quality of patient care.
Cardiology January 29th 2024
The New England Journal of Medicine
In a rigorously designed trial involving more than 5,000 participants, researchers observed that testosterone treatment in hypogonadal men aged 45-80 was associated with a 1.43 times higher risk of clinical fractures compared to placebo. These findings are crucial in re-evaluating the therapeutic approach to testosterone replacement in this demographic.
Endocrinology, Diabetes, Metabolism January 22nd 2024
Cleveland Clinic Journal of Medicine
Recent studies reveal that adding ezetimibe to lower-intensity statin therapy is as effective as high-intensity statin therapy alone in preventing major cardiovascular events, offering a new approach to lipid management in patients intolerant to high-intensity statins.
Cardiology January 18th 2024
Psych Congress Network
A recent study reveals a significant association between prolonged ADHD medication use and cardiovascular risk, emphasizing the need for vigilant cardiovascular monitoring in these patients.
Cardiology January 10th 2024
The Epoch Times
Emerging research suggests that statins, while beneficial in some respects, could potentially exacerbate coronary artery calcification and deplete vital heart-protecting nutrients.
Cardiology January 4th 2024
ACP Internist
The recent LODESTAR clinical trial has revealed that although the two statins are equally effective in preventing heart attacks, strokes, and death, one has been associated with a higher risk of developing type 2 diabetes and requiring cataract surgery.
Cardiology November 15th 2023